• 1
    Coppel RL, Gershwin ME. Primary biliary cirrhosis: the molecule and the mimic. Immunol Rev 1995; 144: 1749.
  • 2
    Heseltine L, Turner IB, Fussey SP, Kelly PJ, James OF, Yeaman SJ, Bassendine MF. Primary biliary cirrhosis: quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression. Gastroenterology 1990; 99: 17861792.
  • 3
    Gershwin ME, Mackay IR. Primary biliary cirrhosis: paradigm or paradox for autoimmunity. Gastroenterology 1991; 100: 822833.
  • 4
    Van de Water J, Cooper A, Surh CD, Coppel R, Banner D, Ansari A, Dickson R, et al. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N Engl J Med 1989; 320: 13771380.
  • 5
    Leung PSC, Iwayama T, Prindiville T, Chuang DT, Ansari AA, Wynn RM, Dickson R, et al. Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis. HEPATOLOGY 1992; 15: 367372.
  • 6
    Murtaugh PA, Dickson ER, Van Dam GM, Malinchoc M, Grambsch PM, Langworthy AL, Gips CH. Primary biliary cirrhosis: prediction of short-term survival based on repeated patients visits. HEPATOLOGY 1994; 20: 126134.
  • 7
    Van de Water J, Gershwin ME, Leung P, Ansari A, Coppel RL. The auto-epitope of the 74kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyl transfer as e. J Exp Med 1988; 167: 17911799.
  • 8
    Griffin TA, Wynn RM, Chuang DT. Expression and assembly of mature apotransacylase (E2b) of bovine branched-chain α-keto acid dehydrogenase complex in Escherichia coli. J Biol Chem 1990; 265: 1210412111.
  • 9
    SAS Institute. SAS user's guide: statistics. Version 6 ed. Gary, NC: SAS Institute, 1985.
  • 10
    S-PLUS user's manual. Seattle, WA: Statistical Sciences, Inc., 1991.
  • 11
    Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic primary biliary cirrhosis. N Engl JMed 1983; 308: 17.
  • 12
    Christensen E, Crowe J, Doniach D, Popper V, Ranek L, Roder J, Tygstrup N, et al. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology 1980; 78: 236246.
  • 13
    Matsui M, Nakamura M, Ishibashi H, Koike K, Kudo J, Niho Y. Human monoclonal antibodies from a patient with primary biliary cirrhosis that recognizes two distinct autoepitopes in the E2 component of the pyruvate dehydrogenase complex. HEPATOLOGY 1993; 18: 10691077.
  • 14
    Cha S, Leung P, Coppel RL, Van de Water J, Ansari AA, Gershwin ME. Heterogeneity of combinatorial human autoantibodies against PDC-E2 and biliary epithelial cells on patients with primary biliary cirrhosis. HEPATOLOGY 1994; 20: 574583.
  • 15
    Surh CD, Ahmed-Ansari A, Gershwin ME. Comparative epitope mapping of murine monoclonal and human antibodies to human PDH-E2, the major mitochondrial autoantigen of primary biliary cirrhosis. J Immunol 1990; 144: 26472652.
  • 16
    Surh CD, Coppel R, Gershwin ME. Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis: implication for a conformational autoepitope. J Immunol 1990; 144: 33673374.
  • 17
    Van de Water J, Turchany J, Leung PSC, Lake J, Munoz S, Surh C, Coppel R, et al. Molecular mimicry in primary biliary cirrhosis. J Clin Invest 1993; 91: 26532664.
  • 18
    Tsuneyama K, Van de Water J, Leung PS, Cha S, Nakanuma Y, Kaplan M, et al. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. HEPATOLOGY 1995; 21: 10311037.
  • 19
    Bjorkland A, Loof L, Mendel-Hartvig I, Totterman TH. Primary biliary cirrhosis: high proportions of B cells in blood and liver tissue produce antimitochondrial antibodies of several Ig classes. J Immunol 1994; 153: 27502757.